BG60066B2 - Метод за получаване на 4-/3-/4-оксотиазолидин//бутиниламин - Google Patents
Метод за получаване на 4-/3-/4-оксотиазолидин//бутиниламинInfo
- Publication number
- BG60066B2 BG60066B2 BG094208A BG9420891A BG60066B2 BG 60066 B2 BG60066 B2 BG 60066B2 BG 094208 A BG094208 A BG 094208A BG 9420891 A BG9420891 A BG 9420891A BG 60066 B2 BG60066 B2 BG 60066B2
- Authority
- BG
- Bulgaria
- Prior art keywords
- taken together
- cycloalkane
- spiro
- general formula
- mixed
- Prior art date
Links
- NOLHRFLIXVQPSZ-UHFFFAOYSA-N 1,3-thiazolidin-4-one Chemical compound O=C1CSCN1 NOLHRFLIXVQPSZ-UHFFFAOYSA-N 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000001924 cycloalkanes Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
Съединенията намират приложение в медицината. Те са полезни като аналгетични и антихипертонични средства и имат обща формула в която r1 и r2 поотделно означават водород или нисш алкил или r1 и r2 взети заедно с въглеродния атом, към който са присъединени, образуват спиросмесен циклоалкан с 5 до 8 въглеродни атома; r3 и r4 взети заедно с въглеродния атом, към който са присъединени, образуват спиросмесен циклоалкан с 5 до 8 въглеродни атома; r5 и r6 взети заедно с азотния атом, към който са присъединени, означават пиперазин или пиперидинсъдържащ остатък. Получават се чрез взаимодействие на съединения с обща формула в която r1, r2, r3, r4 и r5 имат посочените значения, с формалдехид или негово производно и съответно заместен амин. 1 претенция
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/509,280 US5034392A (en) | 1990-04-16 | 1990-04-16 | 4-(3-(4-oxothiazolidinyl)butynylamines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG60066B2 true BG60066B2 (bg) | 1993-09-30 |
Family
ID=24025983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG094208A BG60066B2 (bg) | 1990-04-16 | 1991-04-09 | Метод за получаване на 4-/3-/4-оксотиазолидин//бутиниламин |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5034392A (bg) |
| EP (1) | EP0452850B1 (bg) |
| JP (1) | JPH07119223B2 (bg) |
| KR (1) | KR0163598B1 (bg) |
| AR (1) | AR248402A1 (bg) |
| AT (1) | ATE163010T1 (bg) |
| AU (1) | AU636972B2 (bg) |
| BG (1) | BG60066B2 (bg) |
| CA (1) | CA2040489C (bg) |
| CZ (1) | CZ284447B6 (bg) |
| DE (1) | DE69128845T2 (bg) |
| DK (1) | DK0452850T3 (bg) |
| ES (1) | ES2112844T3 (bg) |
| FI (1) | FI94755C (bg) |
| GR (1) | GR3026319T3 (bg) |
| HU (1) | HUT61017A (bg) |
| IE (1) | IE911257A1 (bg) |
| IL (1) | IL97852A (bg) |
| MX (1) | MX25359A (bg) |
| NO (1) | NO300134B1 (bg) |
| NZ (1) | NZ237811A (bg) |
| PL (1) | PL165488B1 (bg) |
| PT (1) | PT97371B (bg) |
| RO (1) | RO108683B1 (bg) |
| RU (1) | RU2001914C1 (bg) |
| ZA (1) | ZA912783B (bg) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5273977A (en) * | 1990-11-05 | 1993-12-28 | Warner-Lambert Company | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| US5147881A (en) * | 1990-11-14 | 1992-09-15 | Pfizer Inc | 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents |
| US5130315A (en) * | 1991-01-10 | 1992-07-14 | Raymond R. Wittekind | 1-piperazinyl-2-butenes and -2-butynes |
| US5194436A (en) * | 1991-01-10 | 1993-03-16 | Hoechst-Roussel Pharmaceuticals Inc. | 1-piperazinyl-2-butenes and -2-butynes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3354178A (en) * | 1965-04-09 | 1967-11-21 | Sterling Drug Inc | Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides |
| EP0316723B1 (en) * | 1987-11-20 | 1992-09-30 | Hoechst-Roussel Pharmaceuticals Incorporated | 3-[4(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinones a process for their preparation and their use as medicaments |
-
1990
- 1990-04-16 US US07/509,280 patent/US5034392A/en not_active Expired - Lifetime
-
1991
- 1991-04-09 BG BG094208A patent/BG60066B2/bg unknown
- 1991-04-12 AR AR91319454A patent/AR248402A1/es active
- 1991-04-12 FI FI911783A patent/FI94755C/fi not_active IP Right Cessation
- 1991-04-12 NZ NZ237811A patent/NZ237811A/en unknown
- 1991-04-12 RO RO147316A patent/RO108683B1/ro unknown
- 1991-04-15 AU AU75028/91A patent/AU636972B2/en not_active Ceased
- 1991-04-15 EP EP91105972A patent/EP0452850B1/en not_active Expired - Lifetime
- 1991-04-15 CA CA002040489A patent/CA2040489C/en not_active Expired - Fee Related
- 1991-04-15 IE IE125791A patent/IE911257A1/en not_active IP Right Cessation
- 1991-04-15 PT PT97371A patent/PT97371B/pt not_active IP Right Cessation
- 1991-04-15 ES ES91105972T patent/ES2112844T3/es not_active Expired - Lifetime
- 1991-04-15 PL PL91289892A patent/PL165488B1/pl unknown
- 1991-04-15 CZ CS911065A patent/CZ284447B6/cs not_active IP Right Cessation
- 1991-04-15 IL IL9785291A patent/IL97852A/en not_active IP Right Cessation
- 1991-04-15 ZA ZA912783A patent/ZA912783B/xx unknown
- 1991-04-15 DE DE69128845T patent/DE69128845T2/de not_active Expired - Fee Related
- 1991-04-15 RU SU914895050A patent/RU2001914C1/ru active
- 1991-04-15 HU HU911239A patent/HUT61017A/hu unknown
- 1991-04-15 DK DK91105972T patent/DK0452850T3/da active
- 1991-04-15 JP JP3109867A patent/JPH07119223B2/ja not_active Expired - Fee Related
- 1991-04-15 MX MX25359A patent/MX25359A/es unknown
- 1991-04-15 NO NO911465A patent/NO300134B1/no unknown
- 1991-04-15 AT AT91105972T patent/ATE163010T1/de not_active IP Right Cessation
- 1991-04-15 KR KR1019910005987A patent/KR0163598B1/ko not_active Expired - Fee Related
-
1998
- 1998-03-11 GR GR980400510T patent/GR3026319T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL68075A0 (en) | Pyridine and pyrane derivatives,their preparation and pharmaceutical compositions containing them | |
| TW234116B (en) | 2-Cyano-3-hydroxy-enamides and their preparation process | |
| EP0390215A3 (en) | Quinolone derivatives and salts thereof, preparation process es thereof, and antibacterial agents containing the same | |
| DE69507293D1 (de) | Benzamid-derivate als vasopressin-antagonisten | |
| DK0474243T3 (da) | 1-methylcarbapenemderivater og fremgangsmåde til fremstilling deraf | |
| MY100115A (en) | Nitrogen containing heterocyclic compounds, and their production and use. | |
| MY131762A (en) | Pharmaceutical compounds | |
| DK0763024T3 (da) | Fremgangmåde og mellemprodukter til fremstilling af piperazinderivater | |
| KR0141683B1 (en) | Naphthoic acid derivative | |
| ES8308543A1 (es) | "procedimiento para la preparacion de nuevas 2-fenil-2-(piridiloxi)-etilaminas sustituidas". | |
| NO940026D0 (no) | Mono- og bis alkylamino-antra-cykliner | |
| ATE106866T1 (de) | N-benzyl-n1-phenyl und -phenalkyl-thioharnstoffe. | |
| ES2120498T3 (es) | Nuevo compuesto tetraciclico. | |
| EP0449195A3 (en) | Aminobenzene compounds, their production and use | |
| ES8500935A1 (es) | Un procedimiento para preparar derivados de piridina. | |
| MY109714A (en) | Process for preparing 8-chloroquinolone derivatives | |
| ES8105704A1 (es) | Procedimiento de preparacion de nuevos eteres oximas, de sussales de adicion acidas y de sus derivados amonicos cuater- narios | |
| ATE148128T1 (de) | Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung | |
| ES2121076T3 (es) | Derivado amido n,n'-disubstituido. | |
| DK182181A (da) | Antihypertensivt virksomme lactamer og fremgangsmaade til fremstilling heraf | |
| HUT60261A (en) | Process for producing piperazine derivatives and pharmaceutical compositions comprising same | |
| KR910007939A (ko) | 헤테로사이클릭 화합물 및 이의 제조방법 | |
| SE429864B (sv) | Forfarande for framstellning av 1-(3-fenyl-propyl-4-furoylpiperaziner | |
| GB2011888A (en) | Aminophenyl Ether Compounds | |
| ES8302712A1 (es) | Un nuevo procedimiento de preparacion de imidazobenzodiazepinas. |